Xilio Therapeutics, Inc. (XLO)
8.94
+0.03
(+0.34%)
USD |
NASDAQ |
Sep 09, 16:00
8.94
0.00 (0.00%)
After-Hours: 16:07
Xilio Therapeutics Total Liabilities (Quarterly) : 81.99M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 81.99M |
| March 31, 2026 | 90.94M |
| December 31, 2025 | 121.42M |
| September 30, 2025 | 141.79M |
| June 30, 2025 | 126.74M |
| March 31, 2025 | 93.02M |
| December 31, 2024 | 53.48M |
| September 30, 2024 | 53.68M |
| June 30, 2024 | 56.46M |
| March 31, 2024 | 56.84M |
| December 31, 2023 | 24.10M |
| September 30, 2023 | 25.34M |
| Date | Value |
|---|---|
| June 30, 2023 | 24.98M |
| March 31, 2023 | 26.71M |
| December 31, 2022 | 33.52M |
| September 30, 2022 | 31.12M |
| June 30, 2022 | 33.91M |
| March 31, 2022 | 30.23M |
| December 31, 2021 | 36.17M |
| September 30, 2021 | 34.29M |
| June 30, 2021 | 38.44M |
| March 31, 2021 | 34.59M |
| December 31, 2020 | 41.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cue Biopharma, Inc. | 28.40M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 154.25M |
| Shareholders Equity (Quarterly) | 72.26M |
| Debt to Equity Ratio | 0.0872 |
| Current Ratio | 4.254 |
| Net Debt Paydown Yield | 0.50% |